agilon health, inc. Proceeds from Collection of Loans Receivable
agilon health, inc. (AGL) reported Proceeds from Collection of Loans Receivable of $15.13 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-03.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromCollectionOfLoansReceivable · last filed 2022-11-03
- agilon health, inc. proceeds from collection of loans receivable for the quarter ending 2022-09-30 was $10.85M, a 30894.29% increase year-over-year.
- agilon health, inc. proceeds from collection of loans receivable for the quarter ending 2022-06-30 was $4.10M, a 220.75% increase year-over-year.
- agilon health, inc. proceeds from collection of loans receivable for the quarter ending 2022-03-31 was $183.00K.
- agilon health, inc. proceeds from collection of loans receivable for the quarter ending 2021-12-31 was $5.78M, a 482.38% increase year-over-year.
- agilon health, inc. proceeds from collection of loans receivable for fiscal 2021 was $7.09M, a 244.75% increase from fiscal 2020.
- agilon health, inc. proceeds from collection of loans receivable for fiscal 2020 was $2.06M.
- agilon health, inc. proceeds from collection of loans receivable for fiscal 2019 was $0.00.
| Period end | Proceeds from Collection of Loans Receivable 3 month | Proceeds from Collection of Loans Receivable 6 month | Proceeds from Collection of Loans Receivable 9 month | Proceeds from Collection of Loans Receivable 12 month |
|---|---|---|---|---|
| 2022-09-30 | $10.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $14.94M derived: sum of 2 quarters · filed 2022-11-03 | $15.13M 10-Q · filed 2022-11-03 | $20.91M derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-06-30 | $4.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $4.28M 10-Q · filed 2022-08-04 | $10.06M derived: sum of 3 quarters · filed 2022-08-04 | $10.10M derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-03-31 | $183.00K 10-Q · filed 2022-05-05 | $5.97M derived: sum of 2 quarters · filed 2022-05-05 | $6.00M derived: sum of 3 quarters · filed 2022-11-03 | $7.28M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-12-31 | $5.78M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $5.82M derived: sum of 2 quarters · filed 2022-11-03 | $7.09M derived: sum of 3 quarters · filed 2022-11-03 | $7.09M 10-K · filed 2022-03-03 |
| 2021-09-30 | $35.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $1.31M derived: sum of 2 quarters · filed 2022-11-03 | $1.31M 10-Q · filed 2022-11-03 | $2.31M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | $1.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $1.28M 10-Q · filed 2022-08-04 | $2.27M derived: sum of 3 quarters · filed 2022-08-04 | $2.27M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-05 | $993.00K derived: sum of 2 quarters · filed 2022-05-05 | $996.00K derived: sum of 3 quarters · filed 2022-05-05 | $1.00M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $993.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $996.00K derived: sum of 2 quarters · filed 2022-03-03 | $1.00M derived: sum of 3 quarters · filed 2022-03-03 | $2.06M 10-K · filed 2022-03-03 |
| 2020-09-30 | $3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $9.00K derived: sum of 2 quarters · filed 2021-10-28 | $1.06M 10-Q · filed 2021-10-28 | |
| 2020-06-30 | $6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $1.06M 10-Q · filed 2021-08-04 | ||
| 2020-03-31 | $1.06M 10-Q · filed 2021-05-26 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |